Big Technologies And 2 Other UK Penny Stocks To Watch

In This Article:

Over the last 7 days, the UK market has remained flat, while it has risen 6.1% over the past year and earnings are forecast to grow by 15% annually. For those looking to invest in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

Top 10 Penny Stocks In The United Kingdom

Name

Share Price

Market Cap

Financial Health Rating

ME Group International (LSE:MEGP)

£2.115

£796.86M

★★★★★★

Next 15 Group (AIM:NFG)

£3.76

£373.95M

★★★★☆☆

Solid State (AIM:SOLI)

£1.202751

£69.6M

★★★★★★

Serabi Gold (AIM:SRB)

£0.8975

£67.4M

★★★★★★

Supreme (AIM:SUP)

£1.635825

£190.08M

★★★★★★

Ultimate Products (LSE:ULTP)

£1.225

£104.12M

★★★★★★

Luceco (LSE:LUCE)

£1.278

£197.1M

★★★★★☆

Stelrad Group (LSE:SRAD)

£1.38

£175.75M

★★★★★☆

Integrated Diagnostics Holdings (LSE:IDHC)

$0.39

$226.72M

★★★★★★

Impax Asset Management Group (AIM:IPX)

£3.20

£409.48M

★★★★★★

Click here to see the full list of 463 stocks from our UK Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Big Technologies

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Big Technologies PLC develops and delivers remote monitoring technologies and services for the offender and remote personal monitoring industry under the Buddi brand across the Americas, Europe, and Asia-Pacific, with a market cap of £394.46 million.

Operations: The company generates £54.45 million in revenue from its electronic tracking devices, products, and services segment.

Market Cap: £394.46M

Big Technologies PLC, with a market cap of £394.46 million, is debt-free and maintains high-quality earnings, although recent earnings growth has been negative. The company reported a drop in net income for the half-year ending June 2024, at £3.94 million compared to £8.99 million previously. Despite this, its short-term assets significantly exceed both short and long-term liabilities. The firm recently initiated a share buyback program to repurchase up to 5 million shares by mid-2025, reflecting confidence in its financial stability despite reduced profit margins from last year’s 36.4% to the current 23%.

AIM:BIG Financial Position Analysis as at Nov 2024
AIM:BIG Financial Position Analysis as at Nov 2024

Eden Research

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Eden Research plc, with a market cap of £20.27 million, develops and sells biopesticide solutions for crop protection, animal health, and consumer products industries in the United Kingdom and Europe.